The global Immunology Market size is projected to reach a CAGR of 8.1% from 2023-2030.
Immunology is a discipline of medical and biological research that studies the immune system. The immune system defends us against infection in a variety of ways. Diseases such as autoimmunity, allergies, and cancer can occur when the human immune system is not operating properly. Autoimmune diseases occur when the immune system attacks the body that it’s meant to protect. People suffering from autoimmune diseases have a defect that makes their immune system unable to distinguish 'self' from ‘non-self’ or 'foreign' molecules.
Get Free Sample Report@ https://www.delvens.com/get-free-sample/immunology-market
The growth of the market can be attributed to various factors such as the Increasing prevalence of autoimmune disorders and increasing product approvals by regulatory agencies. Furthermore, increasing funding from various government and non-government organizations is also an important factor responsible for the growth of the market.
On the other hand, the high costs of immunology drugs, adverse effects associated with these drugs, and lack of awareness are the major factors that can hinder the growth of the global immunology market.
Recent Developments
· August 29, 2022 - AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin Diseases at the European Academy of Dermatology and Venereology (EADV).
· August 24, 2022 - AbbVie announced that the U.S. Food and Drug Administration (FDA) approved the use of IMBRUVICA® (ibrutinib) for the treatment of pediatric patients one year and older with chronic graft versus host disease (cGVHD) after the failure of one or more lines of systemic therapy.
Prominent Players
· AbbVie Inc.
· Janssen Global Services
· Johnson & Johnson
· F. Hoffmann-La Roche Ltd
· Amgen Inc.
· Pfizer Inc.
· Novartis
· Astellas
· Bristol-Myers Squibb Company
· Merck Sharp & Dohme Corp.
· UCB SA
· Allergan plc
For More Inquiry@ https://www.delvens.com/Inquire-before-buying/immunology-market
North America to Dominate the Market
North America has the largest share in the immunology drug market because of the availability of better reimbursement policies, the high potential to invest a huge amount of money in the development of immunology drugs, and due to the advancement of technologies.
Immunology Market Segmentation:
On the basis of the drug class
· Monoclonal Antibody (mAb)
· Fusion Proteins
· Immunosuppressants
Based on disease indication
· Rheumatoid Arthritis
· Psoriatic Arthritis
· Plaque Psoriasis
· Ankylosing Spondylitis
Based on the distribution channel
· Hospital Pharmacies
· Retail Pharmacies
· Online Pharmacies
Based on region:
· Asia Pacific
· North America
· Europe
· South America
· Middle East & Africa
Get Detailed Report@ https://www.delvens.com/report/immunology-market
Frequently Asked Questions
· What are the years considered to study Immunology Market?
· What is the compound annual growth rate (CAGR) of the Immunology Market?
· Which region holds the largest market share in Immunology Market?
· Which region is the fastest growing region in Immunology Market?
· Who are the major players in Immunology Market?
In addition to the market data for Immunology Market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.
More Related Reports:
Multiple Sclerosis (MS) Market
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
Comments
0 comment